サマリー

マイクロケモセラピーとは、あらゆる病気を治療するためにあらゆる薬剤を使用することです。しかし、ほとんどの人にとって、マイクロ化学療法とは、がん治療に使われる薬剤を意味します。
市場分析と洞察。マイクロ化学療法の世界市場
COVID-19のパンデミックにより、マイクロ化学療法の世界市場規模は2022年には百万米ドルと推定され、検討期間中のCAGRは%で2028年には百万米ドルに再調整されると予測されています。この健康危機による経済的変化を十分に考慮して、医学療法は2021年にマイクロ化学療法の世界市場の％を占めていますが、COVID-19後の期間には改訂された％のCAGRで成長し、2028年には100万米ドルになると予測されています。一方、病院のセグメントは、この予測期間中、％のCAGRで変化しています。
中国のマイクロ化学療法の市場規模は2021年に百万米ドル、米国と欧州のマイクロ化学療法はそれぞれ百万米ドルと百万米ドルとなっています。米国の割合は2021年には%ですが、中国と欧州はそれぞれ%と%であり、中国の割合は2028年には%に達し、分析期間中のCAGRは%になると予測されます。アジアでは、日本、韓国、東南アジアが注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。欧州のマイクロ化学療法市場では、ドイツが2028年までに100万米ドルに達すると予測されており、予測期間中のCAGRは%です。
マイクロ化学療法の世界的な主要メーカーには、Amgen、Celgene、MagForce AG、Nanotherapeutics、Spectrum Pharmaceuticals、Ablynx（Sanofi）、AMAG、CytImmune、Delporなどがあります。2021年には、世界の上位5社の売上高シェアは約%となっています。
世界のマイクロ化学療法の範囲とセグメント
マイクロ化学療法の市場は、タイプ別、アプリケーション別に分類されています。世界のマイクロ化学療法市場のプレーヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント分析では、2017年から2028年の期間におけるタイプ別、アプリケーション別の売上高、収益、予測に焦点を当てています。
タイプ別セグメント
薬物療法
物理療法（Physical Therapy
その他
アプリケーション別
病院
クリニック
その他
会社別
アムジェン
セルジーン
MagForce AG
Nanotherapeutics
スペクトラム・ファーマシューティカルズ
Ablynx(Sanofi)
AMAG
CytImmune
デルポール
Nanospectra
メリマク
タルベダ
地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

ページTOPに戻る

目次

1 Study Coverage
1.1 Micro Chemotherapy Product Introduction
1.2 Market by Type
1.2.1 Global Micro Chemotherapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Medicine Therapy
1.2.3 Physical Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Micro Chemotherapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Micro Chemotherapy Sales Estimates and Forecasts 2017-2028
2.2 Global Micro Chemotherapy Revenue Estimates and Forecasts 2017-2028
2.3 Global Micro Chemotherapy Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Micro Chemotherapy Sales by Region
2.4.1 Global Micro Chemotherapy Sales by Region (2017-2022)
2.4.2 Global Sales Micro Chemotherapy by Region (2023-2028)
2.5 Global Micro Chemotherapy Revenue by Region
2.5.1 Global Micro Chemotherapy Revenue by Region (2017-2022)
2.5.2 Global Micro Chemotherapy Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Micro Chemotherapy Sales by Manufacturers
3.1.1 Global Top Micro Chemotherapy Manufacturers by Sales (2017-2022)
3.1.2 Global Micro Chemotherapy Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Micro Chemotherapy in 2021
3.2 Global Micro Chemotherapy Revenue by Manufacturers
3.2.1 Global Micro Chemotherapy Revenue by Manufacturers (2017-2022)
3.2.2 Global Micro Chemotherapy Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Micro Chemotherapy Revenue in 2021
3.3 Global Micro Chemotherapy Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Micro Chemotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Micro Chemotherapy Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Micro Chemotherapy Sales by Type
4.1.1 Global Micro Chemotherapy Historical Sales by Type (2017-2022)
4.1.2 Global Micro Chemotherapy Forecasted Sales by Type (2023-2028)
4.1.3 Global Micro Chemotherapy Sales Market Share by Type (2017-2028)
4.2 Global Micro Chemotherapy Revenue by Type
4.2.1 Global Micro Chemotherapy Historical Revenue by Type (2017-2022)
4.2.2 Global Micro Chemotherapy Forecasted Revenue by Type (2023-2028)
4.2.3 Global Micro Chemotherapy Revenue Market Share by Type (2017-2028)
4.3 Global Micro Chemotherapy Price by Type
4.3.1 Global Micro Chemotherapy Price by Type (2017-2022)
4.3.2 Global Micro Chemotherapy Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Micro Chemotherapy Sales by Application
5.1.1 Global Micro Chemotherapy Historical Sales by Application (2017-2022)
5.1.2 Global Micro Chemotherapy Forecasted Sales by Application (2023-2028)
5.1.3 Global Micro Chemotherapy Sales Market Share by Application (2017-2028)
5.2 Global Micro Chemotherapy Revenue by Application
5.2.1 Global Micro Chemotherapy Historical Revenue by Application (2017-2022)
5.2.2 Global Micro Chemotherapy Forecasted Revenue by Application (2023-2028)
5.2.3 Global Micro Chemotherapy Revenue Market Share by Application (2017-2028)
5.3 Global Micro Chemotherapy Price by Application
5.3.1 Global Micro Chemotherapy Price by Application (2017-2022)
5.3.2 Global Micro Chemotherapy Price Forecast by Application (2023-2028)
6 North America
6.1 North America Micro Chemotherapy Market Size by Type
6.1.1 North America Micro Chemotherapy Sales by Type (2017-2028)
6.1.2 North America Micro Chemotherapy Revenue by Type (2017-2028)
6.2 North America Micro Chemotherapy Market Size by Application
6.2.1 North America Micro Chemotherapy Sales by Application (2017-2028)
6.2.2 North America Micro Chemotherapy Revenue by Application (2017-2028)
6.3 North America Micro Chemotherapy Market Size by Country
6.3.1 North America Micro Chemotherapy Sales by Country (2017-2028)
6.3.2 North America Micro Chemotherapy Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Micro Chemotherapy Market Size by Type
7.1.1 Europe Micro Chemotherapy Sales by Type (2017-2028)
7.1.2 Europe Micro Chemotherapy Revenue by Type (2017-2028)
7.2 Europe Micro Chemotherapy Market Size by Application
7.2.1 Europe Micro Chemotherapy Sales by Application (2017-2028)
7.2.2 Europe Micro Chemotherapy Revenue by Application (2017-2028)
7.3 Europe Micro Chemotherapy Market Size by Country
7.3.1 Europe Micro Chemotherapy Sales by Country (2017-2028)
7.3.2 Europe Micro Chemotherapy Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Micro Chemotherapy Market Size by Type
8.1.1 Asia Pacific Micro Chemotherapy Sales by Type (2017-2028)
8.1.2 Asia Pacific Micro Chemotherapy Revenue by Type (2017-2028)
8.2 Asia Pacific Micro Chemotherapy Market Size by Application
8.2.1 Asia Pacific Micro Chemotherapy Sales by Application (2017-2028)
8.2.2 Asia Pacific Micro Chemotherapy Revenue by Application (2017-2028)
8.3 Asia Pacific Micro Chemotherapy Market Size by Region
8.3.1 Asia Pacific Micro Chemotherapy Sales by Region (2017-2028)
8.3.2 Asia Pacific Micro Chemotherapy Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Micro Chemotherapy Market Size by Type
9.1.1 Latin America Micro Chemotherapy Sales by Type (2017-2028)
9.1.2 Latin America Micro Chemotherapy Revenue by Type (2017-2028)
9.2 Latin America Micro Chemotherapy Market Size by Application
9.2.1 Latin America Micro Chemotherapy Sales by Application (2017-2028)
9.2.2 Latin America Micro Chemotherapy Revenue by Application (2017-2028)
9.3 Latin America Micro Chemotherapy Market Size by Country
9.3.1 Latin America Micro Chemotherapy Sales by Country (2017-2028)
9.3.2 Latin America Micro Chemotherapy Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Micro Chemotherapy Market Size by Type
10.1.1 Middle East and Africa Micro Chemotherapy Sales by Type (2017-2028)
10.1.2 Middle East and Africa Micro Chemotherapy Revenue by Type (2017-2028)
10.2 Middle East and Africa Micro Chemotherapy Market Size by Application
10.2.1 Middle East and Africa Micro Chemotherapy Sales by Application (2017-2028)
10.2.2 Middle East and Africa Micro Chemotherapy Revenue by Application (2017-2028)
10.3 Middle East and Africa Micro Chemotherapy Market Size by Country
10.3.1 Middle East and Africa Micro Chemotherapy Sales by Country (2017-2028)
10.3.2 Middle East and Africa Micro Chemotherapy Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Overview
11.1.3 Amgen Micro Chemotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Amgen Micro Chemotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amgen Recent Developments
11.2 Celgene
11.2.1 Celgene Corporation Information
11.2.2 Celgene Overview
11.2.3 Celgene Micro Chemotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Celgene Micro Chemotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Celgene Recent Developments
11.3 MagForce AG
11.3.1 MagForce AG Corporation Information
11.3.2 MagForce AG Overview
11.3.3 MagForce AG Micro Chemotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 MagForce AG Micro Chemotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 MagForce AG Recent Developments
11.4 Nanotherapeutics
11.4.1 Nanotherapeutics Corporation Information
11.4.2 Nanotherapeutics Overview
11.4.3 Nanotherapeutics Micro Chemotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Nanotherapeutics Micro Chemotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Nanotherapeutics Recent Developments
11.5 Spectrum Pharmaceuticals
11.5.1 Spectrum Pharmaceuticals Corporation Information
11.5.2 Spectrum Pharmaceuticals Overview
11.5.3 Spectrum Pharmaceuticals Micro Chemotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Spectrum Pharmaceuticals Micro Chemotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Spectrum Pharmaceuticals Recent Developments
11.6 Ablynx(Sanofi)
11.6.1 Ablynx(Sanofi) Corporation Information
11.6.2 Ablynx(Sanofi) Overview
11.6.3 Ablynx(Sanofi) Micro Chemotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Ablynx(Sanofi) Micro Chemotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ablynx(Sanofi) Recent Developments
11.7 AMAG
11.7.1 AMAG Corporation Information
11.7.2 AMAG Overview
11.7.3 AMAG Micro Chemotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 AMAG Micro Chemotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 AMAG Recent Developments
11.8 CytImmune
11.8.1 CytImmune Corporation Information
11.8.2 CytImmune Overview
11.8.3 CytImmune Micro Chemotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 CytImmune Micro Chemotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CytImmune Recent Developments
11.9 Delpor
11.9.1 Delpor Corporation Information
11.9.2 Delpor Overview
11.9.3 Delpor Micro Chemotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Delpor Micro Chemotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Delpor Recent Developments
11.10 Nanospectra
11.10.1 Nanospectra Corporation Information
11.10.2 Nanospectra Overview
11.10.3 Nanospectra Micro Chemotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Nanospectra Micro Chemotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nanospectra Recent Developments
11.11 Merrimack
11.11.1 Merrimack Corporation Information
11.11.2 Merrimack Overview
11.11.3 Merrimack Micro Chemotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Merrimack Micro Chemotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Merrimack Recent Developments
11.12 Tarveda
11.12.1 Tarveda Corporation Information
11.12.2 Tarveda Overview
11.12.3 Tarveda Micro Chemotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Tarveda Micro Chemotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Tarveda Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Micro Chemotherapy Industry Chain Analysis
12.2 Micro Chemotherapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Micro Chemotherapy Production Mode & Process
12.4 Micro Chemotherapy Sales and Marketing
12.4.1 Micro Chemotherapy Sales Channels
12.4.2 Micro Chemotherapy Distributors
12.5 Micro Chemotherapy Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Micro Chemotherapy Industry Trends
13.2 Micro Chemotherapy Market Drivers
13.3 Micro Chemotherapy Market Challenges
13.4 Micro Chemotherapy Market Restraints
14 Key Findings in The Global Micro Chemotherapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer